Uterine fibroids are benign tumours of the uterine smooth muscle that are common and affect around 25% of women at some point in their lifetime. They are often multiple and vary in size. While fibroids are usually asymptomatic, they can cause heavy periods, pressure symptoms, pain, and infertility. Treatment options include hysterectomy, myomectomy, uterine artery embolization, and hormonal therapies like GnRH analogues. Fibroids generally do not affect pregnancy but can increase risks of bleeding and preterm delivery.
Uterine fibroids, or leiomyomas, are benign tumors that develop from the smooth muscle cells of the uterus. They are classified based on their location within the uterus. The most common symptoms are abnormal uterine bleeding and pelvic pain or pressure. Risk factors include genetics, race, and hormone levels. Treatment options depend on symptoms and fertility desires, and include medications, surgery such as myomectomy or hysterectomy, uterine artery embolization, and other minimally invasive procedures. Fibroids often change over time through processes such as atrophy, hyaline degeneration, or red degeneration.
Uterine fibroids are non-cancerous tumors that originate from the uterus. They are very common in women of reproductive age, affecting 20-40% of women. Symptoms can include abnormal uterine bleeding, infertility, pain, and pressure. Diagnosis involves physical exam, ultrasound, MRI, and sometimes biopsy. Treatment options include medical management using hormones to shrink fibroids, surgical procedures such as myomectomy to remove fibroids or hysterectomy to remove the uterus, and uterine artery embolization. Nursing care focuses on pain management, monitoring for bleeding and infection, encouraging mobility and nutrition, and providing education and emotional support.
This document summarizes information about fibroid uterus (uterine fibroids). It begins by defining fibroids as benign monoclonal tumors arising in the uterine smooth muscle. It then discusses the etiology, including potential genetic and hormonal factors. Symptoms are outlined, which can include abnormal bleeding, pain, and pressure effects. Diagnostic imaging options like ultrasound, MRI and hysteroscopy are presented. Treatment approaches covered include watchful waiting, medical therapies like hormonal treatments, surgical options like myomectomy and hysterectomy, and uterine artery embolization. Complications, effects on fertility and pregnancy, and new emerging treatment techniques are also summarized.
Fibroids are benign tumors that occur in the uterus and are made of muscle and fibrous tissue. They are very common, affecting at least 20% of women by age 30. Symptoms can include heavy or painful periods, pressure, and infertility. Diagnosis is usually done with ultrasound, MRI, or hysteroscopy. Treatment options include expectant management for small asymptomatic fibroids, medical management to control symptoms or shrink fibroids before surgery, and various surgical procedures like myomectomy (removal of fibroids) or hysterectomy (removal of uterus).
This document discusses the management of uterine fibroids. It covers evaluation including history, examination, and tests. Imaging modalities like ultrasound and hysteroscopy are used to diagnose and characterize fibroids. Small asymptomatic fibroids may not require treatment, while larger or symptomatic fibroids can be managed with drugs, surgery like myomectomy or hysterectomy, or uterine artery embolization. Surgical procedures aim to remove fibroids while preserving the uterus or involve total hysterectomy, and complications are discussed.
The document discusses the internal anatomy of the uterus, defining fibroids as benign tumors arising from the smooth muscles of the uterus. It notes that fibroids are most common in women over 30 and in African/Caribbean women. Symptoms include abnormal uterine bleeding, pain, and pressure effects. Ultrasound is the primary investigation. Treatment options include conservative management, medical therapy using GnRH analogues, and surgical options of myomectomy or hysterectomy depending on factors like age and desire for future fertility. Complications include degeneration, sarcomatous change, infection, and torsion. Differential diagnosis includes other pelvic masses and causes of bleeding. Pregnancy can affect fibroids and fibroids can impact pregnancy
1. Uterine myomas, or fibroids, are benign tumors of the uterine smooth muscle that are very common in women.
2. Fibroids vary greatly in size and can be asymptomatic or cause symptoms like heavy bleeding, pain, or infertility.
3. Risk factors include being between ages 30-40, black race, nulliparity, family history, and excess estrogen levels. Use of oral contraceptives and pregnancies reduce risk.
4. Treatment depends on symptoms and can include observation, medications, myomectomy (surgical removal), or hysterectomy (removal of the uterus). Conservative approaches are recommended when possible.
Uterine fibroids are benign tumours of the uterine smooth muscle that are common and affect around 25% of women at some point in their lifetime. They are often multiple and vary in size. While fibroids are usually asymptomatic, they can cause heavy periods, pressure symptoms, pain, and infertility. Treatment options include hysterectomy, myomectomy, uterine artery embolization, and hormonal therapies like GnRH analogues. Fibroids generally do not affect pregnancy but can increase risks of bleeding and preterm delivery.
Uterine fibroids, or leiomyomas, are benign tumors that develop from the smooth muscle cells of the uterus. They are classified based on their location within the uterus. The most common symptoms are abnormal uterine bleeding and pelvic pain or pressure. Risk factors include genetics, race, and hormone levels. Treatment options depend on symptoms and fertility desires, and include medications, surgery such as myomectomy or hysterectomy, uterine artery embolization, and other minimally invasive procedures. Fibroids often change over time through processes such as atrophy, hyaline degeneration, or red degeneration.
Uterine fibroids are non-cancerous tumors that originate from the uterus. They are very common in women of reproductive age, affecting 20-40% of women. Symptoms can include abnormal uterine bleeding, infertility, pain, and pressure. Diagnosis involves physical exam, ultrasound, MRI, and sometimes biopsy. Treatment options include medical management using hormones to shrink fibroids, surgical procedures such as myomectomy to remove fibroids or hysterectomy to remove the uterus, and uterine artery embolization. Nursing care focuses on pain management, monitoring for bleeding and infection, encouraging mobility and nutrition, and providing education and emotional support.
This document summarizes information about fibroid uterus (uterine fibroids). It begins by defining fibroids as benign monoclonal tumors arising in the uterine smooth muscle. It then discusses the etiology, including potential genetic and hormonal factors. Symptoms are outlined, which can include abnormal bleeding, pain, and pressure effects. Diagnostic imaging options like ultrasound, MRI and hysteroscopy are presented. Treatment approaches covered include watchful waiting, medical therapies like hormonal treatments, surgical options like myomectomy and hysterectomy, and uterine artery embolization. Complications, effects on fertility and pregnancy, and new emerging treatment techniques are also summarized.
Fibroids are benign tumors that occur in the uterus and are made of muscle and fibrous tissue. They are very common, affecting at least 20% of women by age 30. Symptoms can include heavy or painful periods, pressure, and infertility. Diagnosis is usually done with ultrasound, MRI, or hysteroscopy. Treatment options include expectant management for small asymptomatic fibroids, medical management to control symptoms or shrink fibroids before surgery, and various surgical procedures like myomectomy (removal of fibroids) or hysterectomy (removal of uterus).
This document discusses the management of uterine fibroids. It covers evaluation including history, examination, and tests. Imaging modalities like ultrasound and hysteroscopy are used to diagnose and characterize fibroids. Small asymptomatic fibroids may not require treatment, while larger or symptomatic fibroids can be managed with drugs, surgery like myomectomy or hysterectomy, or uterine artery embolization. Surgical procedures aim to remove fibroids while preserving the uterus or involve total hysterectomy, and complications are discussed.
The document discusses the internal anatomy of the uterus, defining fibroids as benign tumors arising from the smooth muscles of the uterus. It notes that fibroids are most common in women over 30 and in African/Caribbean women. Symptoms include abnormal uterine bleeding, pain, and pressure effects. Ultrasound is the primary investigation. Treatment options include conservative management, medical therapy using GnRH analogues, and surgical options of myomectomy or hysterectomy depending on factors like age and desire for future fertility. Complications include degeneration, sarcomatous change, infection, and torsion. Differential diagnosis includes other pelvic masses and causes of bleeding. Pregnancy can affect fibroids and fibroids can impact pregnancy
1. Uterine myomas, or fibroids, are benign tumors of the uterine smooth muscle that are very common in women.
2. Fibroids vary greatly in size and can be asymptomatic or cause symptoms like heavy bleeding, pain, or infertility.
3. Risk factors include being between ages 30-40, black race, nulliparity, family history, and excess estrogen levels. Use of oral contraceptives and pregnancies reduce risk.
4. Treatment depends on symptoms and can include observation, medications, myomectomy (surgical removal), or hysterectomy (removal of the uterus). Conservative approaches are recommended when possible.
Fibroids are benign smooth muscle tumors that originate from the uterus. They are very common in women of reproductive age. Fibroids can vary in size and location within the uterus. Common symptoms include heavy menstrual bleeding, pelvic pressure or pain. Treatment options depend on a woman's symptoms and desire for future fertility. Options include medication, surgical removal of fibroids (myomectomy), or complete hysterectomy. Differential diagnosis of a pelvic mass should consider other potential causes such as ovarian cysts or tumors.
Uterine fibroids, or leiomyomas, are benign tumors that arise from the smooth muscle cells of the uterus. They are the most common solid pelvic tumors in women. While many fibroids do not cause symptoms, they can cause heavy bleeding, pelvic pain or pressure, and problems during pregnancy. Fibroids are diagnosed using ultrasound or other imaging tests and the treatment depends on the severity of symptoms, but may include medication, surgery, or observation.
Fibroids are benign tumors found in the uterus that are dependent on estrogen. They are very common, affecting 20-40% of women, though most do not require treatment. There are different types of fibroids depending on their location. While fibroids are usually asymptomatic, they can cause menstrual disturbances, pressure symptoms, and subfertility. Diagnosis involves clinical examination and ultrasound imaging. Treatment options range from conservative monitoring to medical therapies, uterine artery embolization, myomectomy, and hysterectomy depending on symptoms.
A 30-year old woman presented with a 1.5 year history of something protruding from her vagina along with foul-smelling discharge and irregular periods. Examination and ultrasound revealed a large 15x8 cm cervical fibroid. She underwent a total abdominal hysterectomy to remove the 2 kg fibroid tumor arising from her cervix. Histopathology confirmed it was a cervical fibroid. Cervical fibroids are uncommon but can cause significant growth and surgical difficulties due to their location near the bladder and ureters. The patient recovered well after surgery.
Myoma uteri, also known as uterine fibroids, are benign smooth muscle tumors of the uterus that are quite common. The exact cause is unclear but they are hormonally responsive to estrogen. Symptoms vary depending on the size, position and condition of the fibroids and can include heavy menstrual bleeding, pelvic pressure and pain. Treatment options include medication, myomectomy (surgical removal of the fibroids), or hysterectomy (removal of the uterus). Investigation may involve ultrasound, MRI, or hysteroscopy to determine appropriate treatment.
Uterine fibroids are common non-cancerous tumors that can affect fertility. Submucosal fibroids that distort the uterine cavity have been shown to decrease pregnancy rates, while evidence for intramural fibroids is less clear. Treatment options include medical therapy, uterine artery embolization, hysteroscopic or laparoscopic myomectomy. Myomectomy can improve fertility outcomes, especially for submucosal fibroids, but carries risks of adhesion formation and possible increased risk of uterine rupture in future pregnancies. More research is still needed to fully understand the relationship between fibroid location, size and infertility.
This document discusses fibroids, which are benign growths in the uterus. It notes that fibroids are very common, affecting up to 40% of women, and are more common and symptomatic in black women. While the exact causes are unknown, fibroids develop from the muscle cells of the uterus. The symptoms depend on the location, number, and size of fibroids. Treatment options include medication to manage symptoms, uterine artery embolization to reduce fibroids, and surgical options like myomectomy and hysteroscopic myomectomy to remove fibroids.
Fibroids are the most common benign tumors of the female reproductive system. They arise from the smooth muscle cells of the uterus and affect 20-40% of women of reproductive age. The exact cause is unknown but risk factors include age, family history, obesity, and black race. Symptoms include heavy menstrual bleeding, pain, and a pelvic mass. Diagnosis is usually made clinically or with ultrasound. Treatment depends on symptoms and desire for future fertility, and may include medication, surgery such as myomectomy or hysterectomy, uterine artery embolization, or watchful waiting.
Αριστοτέλης Γ. Αποστολίδης, Απεικόνιση των Ινομυωμάτων και της Αδενομύωσης, 2016. Υπερηχογραφια τομ.13, τευχ.3, σελ. 111-118
ACOG, Uterine Fibroids. Gynecologic Problems, 2018 (Greek Version: Μπαμπάτσιας Λ.)
ACOG, Uterine Fibroids - Frequently Asked Questions: Gynecologic Problems, December 2018
Aymara Mas et al., Updated approaches for management of uterine fibroids. Int J Womens Health. 2017; 9: 607–617. Published online 2017 Sep 5. doi: 10.2147/IJWH.S138982. PMCID: PMC5592915, PMID: 28919823
Hee Joong Lee, MD, et al., Contemporary Management of Fibroids in Pregnancy. Rev Obstet Gynecol. 2010 Winter; 3(1): 20–27. PMCID: PMC2876319. PMID: 20508779
Ioannis K Thanasas, Maria Boursiani, Rare Localizations of Genital Leiomyomas in Woman’s System, October 2015. ACHAIKI IATRIKI Volume 34, Issue 2
Jessica Shields, D.O., Can uterine fibroids harm my pregnancy?, March 31, 2020
Li H, Du J, Jin L, Shi Z, Liu M. Myomectomy during cesarean section. Acta Obstet Gynecol Scand 2009, 88:183-6.
Sharma JB, Kumar S, Rahman SM, Roy KK, Malhotra N. Non-puerperal incomplete uterine inversion due to large sub-mucous fundal fibroid found at hysterectomy: a report of two cases. Arch Gynecol Obstet 2009, 279:565-7.
WebMD, Uterine Fibroids and Pregnancy: How UF Affects Pregnancy. www.webmd.com
The document summarizes guidelines for the management of uterine leiomyomas (fibroids). It discusses various treatment options including medical management with drugs like GnRH agonists, and surgical options like hysterectomy, myomectomy (surgical removal of fibroids), and newer minimally invasive options like uterine artery embolization and laparoscopic myolysis (coagulation of fibroids). It provides details on the risks, benefits, and evidence for each approach and notes that treatment should be individualized based on a woman's symptoms and desire for fertility.
fibroid is a very common disease present in female . and this presentation is about their types, causes, symptoms, risk factor and treatment in females around the world,
disesaes of female reproductive system, and hormonal imbalance causes fibroids in females.
Uterine Fibroids - Women's Health TalkSumma Health
Uterine fibroids are benign tumors that develop in the wall of the uterus. They are most common in women in their 30s and 40s. Symptoms include heavy bleeding, pain, and pressure. Diagnosis involves pelvic exam, ultrasound, or MRI. Treatment options include medication, myomectomy (surgical removal), uterine fibroid embolization (blocking the blood supply), and hysterectomy (removal of the uterus). Uterine fibroid embolization is a minimally invasive treatment performed by interventional radiologists, involving blocking the blood vessels supplying the fibroids.
Uterine fibroid (leiomyoma) and new treatment modalitiesMohammed Saadi
This presentation describes Uterine fibroid
Definition
Incidence
Etiology
Risk factors
Clinical manifestation
Red degeneration
Complications of fibroids
Management and the new modalities in treatment
Leiomyomas, also known as uterine fibroids, are benign muscle tumors of the uterus that are composed of smooth muscle and fibrous connective tissue. They are very common, affecting 25% of white women and 50% of black women. The exact causes are unknown but they are influenced by estrogen levels and may be genetically predisposed. Leiomyomas can cause heavy bleeding, pain, pressure effects, and infertility. Diagnosis involves imaging like ultrasound and treatment options include medication, surgery, or watchful waiting depending on symptoms.
This document discusses uterine fibroids, also known as leiomyomas. It defines a fibroid as a benign smooth muscle tumor of the uterine wall. Fibroids are very common, affecting 25-50% of women. While the exact cause is unknown, estrogen is thought to play a role in growth. Fibroids can cause heavy bleeding, pain, pressure effects, and infertility. Diagnosis involves imaging like ultrasound and treatment depends on factors like age, symptoms, and desire for future pregnancy. Options include observation, medication, myomectomy (surgical removal), or hysterectomy.
Definition of fibroid / uterine leiomyoma
Diagnosis of Fibroid
Treatment of uterine fibroid
Surgery for uterine fibroid
When is surrogacy required for fibroid
By Dr Gajendra Tomar, Indore Infertility Clinic, IVF center
This document discusses leiomyomas (uterine fibroids), including their epidemiology, pathology, classification, symptoms, diagnoses, and various treatment options. Uterine fibroids are benign smooth muscle tumors that commonly occur in women of reproductive age. They are estrogen dependent and rarely cancerous. Treatment options include monitoring, medical therapies to shrink fibroids, arterial embolization, ablation therapies, myomectomy (removal of just the fibroids), and hysterectomy (removal of the entire uterus). Prevention focuses on maintaining a healthy weight and diet to help control estrogen levels.
- National security adviser Condoleezza Rice underwent successful surgery on Friday, November 19, 2004.
- Rice is doing well and resting comfortably after the surgery.
- She is expected to return to work on the following Monday.
This document discusses fibroid uterus (uterine fibroids). It begins by describing fibroids as benign smooth muscle tumors in the uterus that contain extracellular matrix. It then covers the etiology, including genetic and hormonal factors. Risk factors discussed include age, hormones, family history, ethnicity, weight, exercise, oral contraceptive use, pregnancy, and smoking. The document outlines growth factors that promote fibroid growth and details pathology findings. It discusses symptoms, diagnosis, effects on fertility and pregnancy. Various treatment options are covered including medical therapies, surgical procedures like myomectomy and uterine artery embolization, and potential fibroid degenerations.
This document discusses dysfunctional uterine bleeding and treatment options. It describes severe acute bleeding and irregular bleeding as types of dysfunctional uterine bleeding. It recommends using oral contraceptive pills or progestin therapy to treat irregular bleeding and menorrhagia. The combination oral contraceptive pill is suggested to regulate cycles and reduce bleeding, while progestin therapy involves using medications like medroxyprogesterone daily for 14 days each month. Lab tests and imaging may be used to diagnose underlying causes before starting hormonal treatment.
Kurchi bark comes from the Holarrhena antidysentrica plant and is used in traditional Indian medicine. It contains several steroidal alkaloids, primarily conessine, that are effective against amoebic dysentery. The document outlines the names of kurchi bark in various Indian languages, where it is found in India, its physical characteristics, constituents including alkaloids and steroidal compounds, chemical tests to identify steroidal moieties, and its traditional therapeutic uses such as treating amoebiasis.
Fibroids are benign smooth muscle tumors that originate from the uterus. They are very common in women of reproductive age. Fibroids can vary in size and location within the uterus. Common symptoms include heavy menstrual bleeding, pelvic pressure or pain. Treatment options depend on a woman's symptoms and desire for future fertility. Options include medication, surgical removal of fibroids (myomectomy), or complete hysterectomy. Differential diagnosis of a pelvic mass should consider other potential causes such as ovarian cysts or tumors.
Uterine fibroids, or leiomyomas, are benign tumors that arise from the smooth muscle cells of the uterus. They are the most common solid pelvic tumors in women. While many fibroids do not cause symptoms, they can cause heavy bleeding, pelvic pain or pressure, and problems during pregnancy. Fibroids are diagnosed using ultrasound or other imaging tests and the treatment depends on the severity of symptoms, but may include medication, surgery, or observation.
Fibroids are benign tumors found in the uterus that are dependent on estrogen. They are very common, affecting 20-40% of women, though most do not require treatment. There are different types of fibroids depending on their location. While fibroids are usually asymptomatic, they can cause menstrual disturbances, pressure symptoms, and subfertility. Diagnosis involves clinical examination and ultrasound imaging. Treatment options range from conservative monitoring to medical therapies, uterine artery embolization, myomectomy, and hysterectomy depending on symptoms.
A 30-year old woman presented with a 1.5 year history of something protruding from her vagina along with foul-smelling discharge and irregular periods. Examination and ultrasound revealed a large 15x8 cm cervical fibroid. She underwent a total abdominal hysterectomy to remove the 2 kg fibroid tumor arising from her cervix. Histopathology confirmed it was a cervical fibroid. Cervical fibroids are uncommon but can cause significant growth and surgical difficulties due to their location near the bladder and ureters. The patient recovered well after surgery.
Myoma uteri, also known as uterine fibroids, are benign smooth muscle tumors of the uterus that are quite common. The exact cause is unclear but they are hormonally responsive to estrogen. Symptoms vary depending on the size, position and condition of the fibroids and can include heavy menstrual bleeding, pelvic pressure and pain. Treatment options include medication, myomectomy (surgical removal of the fibroids), or hysterectomy (removal of the uterus). Investigation may involve ultrasound, MRI, or hysteroscopy to determine appropriate treatment.
Uterine fibroids are common non-cancerous tumors that can affect fertility. Submucosal fibroids that distort the uterine cavity have been shown to decrease pregnancy rates, while evidence for intramural fibroids is less clear. Treatment options include medical therapy, uterine artery embolization, hysteroscopic or laparoscopic myomectomy. Myomectomy can improve fertility outcomes, especially for submucosal fibroids, but carries risks of adhesion formation and possible increased risk of uterine rupture in future pregnancies. More research is still needed to fully understand the relationship between fibroid location, size and infertility.
This document discusses fibroids, which are benign growths in the uterus. It notes that fibroids are very common, affecting up to 40% of women, and are more common and symptomatic in black women. While the exact causes are unknown, fibroids develop from the muscle cells of the uterus. The symptoms depend on the location, number, and size of fibroids. Treatment options include medication to manage symptoms, uterine artery embolization to reduce fibroids, and surgical options like myomectomy and hysteroscopic myomectomy to remove fibroids.
Fibroids are the most common benign tumors of the female reproductive system. They arise from the smooth muscle cells of the uterus and affect 20-40% of women of reproductive age. The exact cause is unknown but risk factors include age, family history, obesity, and black race. Symptoms include heavy menstrual bleeding, pain, and a pelvic mass. Diagnosis is usually made clinically or with ultrasound. Treatment depends on symptoms and desire for future fertility, and may include medication, surgery such as myomectomy or hysterectomy, uterine artery embolization, or watchful waiting.
Αριστοτέλης Γ. Αποστολίδης, Απεικόνιση των Ινομυωμάτων και της Αδενομύωσης, 2016. Υπερηχογραφια τομ.13, τευχ.3, σελ. 111-118
ACOG, Uterine Fibroids. Gynecologic Problems, 2018 (Greek Version: Μπαμπάτσιας Λ.)
ACOG, Uterine Fibroids - Frequently Asked Questions: Gynecologic Problems, December 2018
Aymara Mas et al., Updated approaches for management of uterine fibroids. Int J Womens Health. 2017; 9: 607–617. Published online 2017 Sep 5. doi: 10.2147/IJWH.S138982. PMCID: PMC5592915, PMID: 28919823
Hee Joong Lee, MD, et al., Contemporary Management of Fibroids in Pregnancy. Rev Obstet Gynecol. 2010 Winter; 3(1): 20–27. PMCID: PMC2876319. PMID: 20508779
Ioannis K Thanasas, Maria Boursiani, Rare Localizations of Genital Leiomyomas in Woman’s System, October 2015. ACHAIKI IATRIKI Volume 34, Issue 2
Jessica Shields, D.O., Can uterine fibroids harm my pregnancy?, March 31, 2020
Li H, Du J, Jin L, Shi Z, Liu M. Myomectomy during cesarean section. Acta Obstet Gynecol Scand 2009, 88:183-6.
Sharma JB, Kumar S, Rahman SM, Roy KK, Malhotra N. Non-puerperal incomplete uterine inversion due to large sub-mucous fundal fibroid found at hysterectomy: a report of two cases. Arch Gynecol Obstet 2009, 279:565-7.
WebMD, Uterine Fibroids and Pregnancy: How UF Affects Pregnancy. www.webmd.com
The document summarizes guidelines for the management of uterine leiomyomas (fibroids). It discusses various treatment options including medical management with drugs like GnRH agonists, and surgical options like hysterectomy, myomectomy (surgical removal of fibroids), and newer minimally invasive options like uterine artery embolization and laparoscopic myolysis (coagulation of fibroids). It provides details on the risks, benefits, and evidence for each approach and notes that treatment should be individualized based on a woman's symptoms and desire for fertility.
fibroid is a very common disease present in female . and this presentation is about their types, causes, symptoms, risk factor and treatment in females around the world,
disesaes of female reproductive system, and hormonal imbalance causes fibroids in females.
Uterine Fibroids - Women's Health TalkSumma Health
Uterine fibroids are benign tumors that develop in the wall of the uterus. They are most common in women in their 30s and 40s. Symptoms include heavy bleeding, pain, and pressure. Diagnosis involves pelvic exam, ultrasound, or MRI. Treatment options include medication, myomectomy (surgical removal), uterine fibroid embolization (blocking the blood supply), and hysterectomy (removal of the uterus). Uterine fibroid embolization is a minimally invasive treatment performed by interventional radiologists, involving blocking the blood vessels supplying the fibroids.
Uterine fibroid (leiomyoma) and new treatment modalitiesMohammed Saadi
This presentation describes Uterine fibroid
Definition
Incidence
Etiology
Risk factors
Clinical manifestation
Red degeneration
Complications of fibroids
Management and the new modalities in treatment
Leiomyomas, also known as uterine fibroids, are benign muscle tumors of the uterus that are composed of smooth muscle and fibrous connective tissue. They are very common, affecting 25% of white women and 50% of black women. The exact causes are unknown but they are influenced by estrogen levels and may be genetically predisposed. Leiomyomas can cause heavy bleeding, pain, pressure effects, and infertility. Diagnosis involves imaging like ultrasound and treatment options include medication, surgery, or watchful waiting depending on symptoms.
This document discusses uterine fibroids, also known as leiomyomas. It defines a fibroid as a benign smooth muscle tumor of the uterine wall. Fibroids are very common, affecting 25-50% of women. While the exact cause is unknown, estrogen is thought to play a role in growth. Fibroids can cause heavy bleeding, pain, pressure effects, and infertility. Diagnosis involves imaging like ultrasound and treatment depends on factors like age, symptoms, and desire for future pregnancy. Options include observation, medication, myomectomy (surgical removal), or hysterectomy.
Definition of fibroid / uterine leiomyoma
Diagnosis of Fibroid
Treatment of uterine fibroid
Surgery for uterine fibroid
When is surrogacy required for fibroid
By Dr Gajendra Tomar, Indore Infertility Clinic, IVF center
This document discusses leiomyomas (uterine fibroids), including their epidemiology, pathology, classification, symptoms, diagnoses, and various treatment options. Uterine fibroids are benign smooth muscle tumors that commonly occur in women of reproductive age. They are estrogen dependent and rarely cancerous. Treatment options include monitoring, medical therapies to shrink fibroids, arterial embolization, ablation therapies, myomectomy (removal of just the fibroids), and hysterectomy (removal of the entire uterus). Prevention focuses on maintaining a healthy weight and diet to help control estrogen levels.
- National security adviser Condoleezza Rice underwent successful surgery on Friday, November 19, 2004.
- Rice is doing well and resting comfortably after the surgery.
- She is expected to return to work on the following Monday.
This document discusses fibroid uterus (uterine fibroids). It begins by describing fibroids as benign smooth muscle tumors in the uterus that contain extracellular matrix. It then covers the etiology, including genetic and hormonal factors. Risk factors discussed include age, hormones, family history, ethnicity, weight, exercise, oral contraceptive use, pregnancy, and smoking. The document outlines growth factors that promote fibroid growth and details pathology findings. It discusses symptoms, diagnosis, effects on fertility and pregnancy. Various treatment options are covered including medical therapies, surgical procedures like myomectomy and uterine artery embolization, and potential fibroid degenerations.
This document discusses dysfunctional uterine bleeding and treatment options. It describes severe acute bleeding and irregular bleeding as types of dysfunctional uterine bleeding. It recommends using oral contraceptive pills or progestin therapy to treat irregular bleeding and menorrhagia. The combination oral contraceptive pill is suggested to regulate cycles and reduce bleeding, while progestin therapy involves using medications like medroxyprogesterone daily for 14 days each month. Lab tests and imaging may be used to diagnose underlying causes before starting hormonal treatment.
Kurchi bark comes from the Holarrhena antidysentrica plant and is used in traditional Indian medicine. It contains several steroidal alkaloids, primarily conessine, that are effective against amoebic dysentery. The document outlines the names of kurchi bark in various Indian languages, where it is found in India, its physical characteristics, constituents including alkaloids and steroidal compounds, chemical tests to identify steroidal moieties, and its traditional therapeutic uses such as treating amoebiasis.
This document provides guidelines for the management of menorrhagia (heavy menstrual bleeding). It discusses definitions, assessment, investigation, and treatment options. Assessment involves evaluating blood loss, patterns, pelvic exam, blood counts, and endometrial assessment via ultrasound or biopsy. Treatment includes medical options like NSAIDs, hormones, and intrauterine devices, as well as surgical options like endometrial destruction or hysterectomy. The guidelines were created by an obstetrics and gynecology committee to aid doctors in clinical decision making for menorrhagia patients.
This document outlines a student project on designing an energy efficient house in Peshawar, Pakistan. It includes an introduction describing the motivation for the project due to Pakistan's energy crisis. It then describes the methodology, data collection on Peshawar's climate, and design of the house using passive cooling and heating techniques like earth tubes, green roofs, and cavity walls. The conclusions recommend further research on expanding energy efficient housing designs to more areas and making them more affordable.
This document discusses a tax case involving a corporation, Algue Inc., that claimed a $75,000 deduction for promotional fees paid to individuals. The Commissioner of Internal Revenue disallowed the deduction. The main issues are whether the deduction was correctly disallowed and whether Algue's appeal was timely filed. The Court of Tax Appeals ruled the appeal was timely as Algue's letter of protest suspended the period to appeal. It also found the promotional fees were legitimate business expenses as they were reasonably paid to individuals for services promoting a new corporation's purchase of another company.
This document contains a research paper summary in Nepali on identifying reasons why students score low in mathematics. Some key findings:
- Many students come from families with uneducated or daily wage earning parents, which impacts their studies.
- Over half of students find mathematics difficult compared to other subjects and don't practice enough.
- Financial, physical and family circumstances limit students' ability to regularly attend school and do homework.
The study analyzed test scores and family backgrounds of 37 grade 6 students at a school to understand factors contributing to low mathematics performance. It aims to help improve teaching methods and learning outcomes.
1. Pasien laki-laki berusia 6 tahun dengan keluhan lenting-lenting di seluruh tubuh sejak 1 hari. 2. Status general baik dengan status dermatologi menunjukkan lesi berupa makula, vesikel dan krusta di seluruh tubuh. 3. Diagnosis kerja varicella didukung anamnesis dan pemeriksaan fisik.
This document summarizes a court case between an insurance company (UCPB General Insurance) and an insured company (Masagana Telamart). The key facts are that Masagana had 5 insurance policies with UCPB that expired on May 22, 1992, but tendered payment for renewal on July 13, 1992 after some of its properties burned on June 13, 1992. UCPB refused payment claiming the policies were not renewed in time. However, the court found that UCPB had a past practice of granting Masagana 60-90 day credit for renewal payments, and that UCPB did not provide timely notice of non-renewal as required. Therefore, the court ruled the policies were effectively renewed and
This document summarizes key aspects of the historical foundations of the Australian legal system, which draws from English common law traditions. It discusses how the Anglo-Saxons introduced concepts like subjection to law and written documents like writs. The Norman conquest introduced feudal systems and the Doomsday book. Over time, the royal courts like the Curia Regis, Eyre courts, and courts of Common Pleas were established. Trial by jury emerged under Henry II. The Magna Carta in 1215 limited royal power. Ecclesiastical courts handled issues like marriage until the mid-1800s. Equity courts developed to provide remedies when common law was insufficient. Criminal and civil law were less distinct historically. The English civil war
This document is a summary of a court case involving Jose B. Ledesma, the former president of West Visayas College. The case centered around Ledesma failing to allow student Violeta Delmo to graduate with honors, as directed by the Director of the Bureau of Public Schools. The court found that Ledesma acted in bad faith and with prejudice against Delmo. The court affirmed the trial court's ruling that Ledesma was liable for damages under the Civil Code due to causing Delmo mental anguish and humiliation. While exemplary damages were appropriate due to Ledesma's defiance of his superior, separate damages for Delmo's parents were removed. The petition to reverse the ruling was dismissed.
- Meena Devi was from a poor family that struggled to meet basic needs through small-scale farming.
- She joined a JEEVIKA self-help group in 2008 and took on leadership roles, using loans to start a dairy business.
- This improved her family's economic situation and allowed investments in her children's education and health. She has become a model of success for her community through her hard work.
This document contains a case scenario and questions about a 62-year-old male patient named J.T. admitted to the ward with increasing weakness, chest heaviness, swelling in his ankles and feet, and nocturnal diuresis. The patient has a history of COPD, diabetes, hypertension, CHF, and smoking. On admission, he has signs of respiratory distress and potential cardiac issues. The document provides the case and asks questions to assess the reader's understanding of the patient's condition, related pathophysiology, appropriate orders and nursing care.
The document discusses whether relocating Opel Overseas, a handicraft exporter based in Jaipur, India, to the Mahindra World City Special Economic Zone would provide competitive and cost advantages. It analyzes the benefits of relocating such as tax exemptions, duty-free imports, and lower land costs. Financial analyses including payback period and accounting rate of return are used to evaluate the investment. The conclusion is that relocating would reduce operational costs and give competitive advantages, but a detailed business plan is needed first.
This document provides a literature review on the topic of innovation and market leadership. It discusses key concepts such as Joseph Schumpeter's view of innovation as the process of "creative destruction" driving economic development. It also summarizes various definitions of innovation from scholars, including the OECD's classification of four main types: product, process, organizational, and marketing innovations. The literature highlights that an innovative culture with total leadership commitment is critical for an organization to develop innovative competence. It concludes that innovation is a multi-dimensional concept encompassing new products/services, processes, behaviors, and infrastructure, and is closely linked to an organization having a market-oriented culture.
Uterine leiomyomas, or fibroids, are benign smooth muscle tumors that are the most common pelvic tumor in women. Fibroids can be described by their location in the uterus and may cause abnormal uterine bleeding, pelvic pressure and pain, or reproductive dysfunction. Symptoms are often relieved at menopause.
A Retrospective Study on Evaluation of Patients with Uterine Fibroid in a Ter...ijtsrd
Uterine fibroids are a major cause of morbidity in women of reproductive age. Hence it is important to evaluate the occurrence of fibroid. An observational retrospective study was carried out in Obstetric and Gynecology Department over a period of 2 months. Each of the cases was scrutinized for sociodemographic, clinical profile and other necessary information. In this study, Fibroid was found to be predominant in premenopausal women. .Parity and number of abortions had no much significance with fibroid diagnosed. The primary management of obese patients were found as weight reduction and diet control. Hysterectomy was done based on large fibroid size. Anju Mam Thomas | Blessy Rachal Boban | Jiya Ann Mathew "A Retrospective Study on Evaluation of Patients with Uterine Fibroid in a Tertiary Care Hospital" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-2 , February 2019, URL: https://www.ijtsrd.com/papers/ijtsrd20311.pdf
Paper URL: https://www.ijtsrd.com/pharmacy/pharmacy-practice/20311/a-retrospective-study-on-evaluation-of-patients-with-uterine-fibroid-in-a-tertiary-care-hospital/anju-mam-thomas
Benign disease of the uterus includes fibroids, adenomyosis, and uterine polyps. Endometrial polyps are common growths in the uterus that can cause abnormal bleeding. They are more frequently seen in women taking medications like tamoxifen. Uterine fibroids are also very common non-cancerous growths that arise from the muscle cells of the uterus and can cause heavy bleeding and pain. While many fibroids cause no issues, some may lead to complications like infertility or problems in pregnancy. Diagnosis is often done with ultrasound or MRI. Treatment depends on symptoms but may include medication, surgery, or watchful waiting.
gynaecology.Benign tumor of the uterus.(dr.sundus)student
Benign disease of the uterus includes fibroids, adenomyosis, and uterine polyps. Fibroids are non-cancerous tumors that form in the uterus and are very common. They can cause heavy bleeding and pain. Uterine polyps are overgrowths of tissue in the uterus that can also cause abnormal bleeding. While many women do not experience symptoms, fibroids and polyps sometimes require treatment such as surgery to remove them.
This document discusses pelvic masses, leiomyomas (uterine fibroids), low abdominal pain, and pelvic inflammatory disease (PID). It begins by defining pelvic masses and describing common causes such as leiomyomas. It then discusses symptoms, diagnosis, and management of leiomyomas. The document outlines signs and potential causes of both acute and chronic lower abdominal pain. Finally, it defines PID, describes risk factors and classifications, and provides epidemiological information about PID.
Recurrent miscarriages need to be investigated actually. You had live births but now had four consecutive miscarriages. It is better to have a thrombophilia screen and products of conception needed to be send out for histopathology to check any chromosomal, congenital, structural anomaly.
Read More:https://www.icliniq.com/qa/miscarriage/why-am-i-having-frequent-miscarriages
A leiomyoma is a benign smooth muscle tumor that originates in the uterus. They are very common, affecting 20-40% of women during their reproductive years. The most common symptoms are abnormal uterine bleeding, pelvic pressure or pain. Treatment options include observation, medication/hormonal therapy, myomectomy (surgical removal), or hysterectomy depending on the severity of symptoms, size and location of fibroids, and desire for future fertility. Laparoscopic and vaginal approaches for myomectomy have benefits of less pain and faster recovery compared to open abdominal myomectomy.
This document provides background information on ovarian cancer, including its pathophysiology, etiology, epidemiology, clinical presentation, diagnosis, and screening. It states that ovarian cancer typically spreads within the peritoneal cavity. Several risk factors are identified, including genetic and reproductive factors. Epithelial ovarian cancer represents the most common histology and has a poor prognosis when diagnosed at advanced stages, due to nonspecific symptoms. No approved screening methods exist for ovarian cancer detection.
Endometriosis is a condition where endometrial tissue grows outside the uterus, often resulting in pelvic pain and infertility. Key points:
- It is most common in women of reproductive age and is characterized by dysfunctional uterine tissue implants in the pelvis that cause pain, especially during periods.
- Diagnosis requires laparoscopy to visualize the implants. Treatment depends on severity and reproductive plans, and may include expectant care, hormonal therapies like oral contraceptives to induce pseudopregnancy, or surgery to remove implants and adhesions.
- Hormonal therapies aim to suppress menstruation and the ectopic endometrial tissue through continuous combination estrogen-progestin pills,
1) Uterine tumors include endometrial polyps, hyperplasia, and carcinomas. Endometrial hyperplasia is classified based on complexity and presence of atypia, with complex hyperplasia with atypia carrying the highest risk of developing into carcinoma.
2) Endometrial carcinomas are classified into Type I (endometrioid) and Type II (non-endometrioid). Type I carcinomas are associated with estrogen excess and hyperplasia, while Type II carcinomas arise in an atrophic endometrium and have a poorer prognosis.
3) Leiomyomas are the most common benign uterine tumor, while leiomyosarcom
The document discusses endometrial carcinoma (cancer of the uterus). It is the most common gynecologic cancer in the US, usually occurring in postmenopausal women. Risk factors include excess estrogen exposure due to obesity, hormone therapy without progestin, anovulation, and tamoxifen use. The document covers epidemiology, risk factors, etiology, histopathology, and classifications of endometrial carcinoma.
The document discusses endometrial hyperplasia and various types of uterine cancers. It defines endometrium as the inner lining of the uterine wall that grows and sheds during menstruation. It describes endometrial hyperplasia as an increased proliferation of endometrial glands relative to the stroma. Endometrial hyperplasia is classified as simple, complex, or atypical depending on the presence of cell changes. The document also discusses endometrial carcinoma, the most common type of which is adenocarcinoma arising from the endometrium. Less common types include sarcomas arising from the uterine stroma or myometrium. Risk factors, diagnosis, staging, treatment, and
This document provides information on endometrial cancer including its definition, incidence, epidemiology, risk factors, clinical presentation, investigation, pathology, classification, staging, and treatment. It notes that endometrial cancer is the most common gynecologic cancer, occurring most often in post-menopausal women. Common risk factors include obesity, diabetes, infertility, and family history. The main symptom is abnormal vaginal bleeding, especially after menopause. Treatment depends on staging and may involve surgery, radiation therapy, chemotherapy, or hormonal therapy.
This document discusses endometriosis and adenomyosis. Endometriosis occurs when endometrial tissue grows outside the uterus, most commonly on the ovaries and pelvic peritoneum. It causes pain and can lead to infertility. Adenomyosis involves the growth of endometrial tissue into the uterine muscle. Both can cause heavy periods and pain. Treatment involves medication, surgery, or hysterectomy depending on symptoms and desire for future fertility.
Uterine Myoma, Risk Factor and Pathophysiology: A Review Articledaranisaha
Uterine myoma is a benign neoplasm composed of uterine smooth muscle and connective tissue that supports it and is often referred to as fibromyoma, leiomyoma, fibroids. Can be single or multiple and reach large sizes (100 pounds). It has a tough consistency, with a clear cap boundary so that it can be removed from the surroundings. Uterine myoma, also known as leiomyoma or fibroid is a benign tumor that is often found in women of reproductive age (20-25%). At age> 35 years the incidence is higher, that is, closer to 40%. The high incidence of uterine myomas between the ages of 35 and the ages of 50 indicates a relationship between the incidence of uterine myomas and estrogen.
Uterine Myoma, Risk Factor and Pathophysiology: A Review ArticleAnonIshanvi
This document reviews uterine myomas (fibroids), including their risk factors and pathophysiology. Some key points:
- Uterine myomas are benign muscle tumors that are common in women of reproductive age. Risk factors include age, family history, ethnicity, obesity, diet, pregnancy history, and smoking.
- The tumors are thought to be sensitive to estrogen and progesterone levels, which may explain why they typically grow during reproductive years and shrink after menopause.
- Cells in uterine myomas have a higher density of estrogen receptors compared to normal uterine muscle cells, and they convert estrogen to weaker forms less efficiently. This creates a relatively hyperestrogenic environment conducive to tumor growth.
Uterine Myoma, Risk Factor and Pathophysiology: A Review ArticleJohnJulie1
Uterine myoma is a benign neoplasm composed of uterine smooth muscle and connective tissue that supports it and is often referred to as fibromyoma, leiomyoma, fibroids. Can be single or multiple and reach large sizes (100 pounds). It has a tough consistency, with a clear cap boundary so that it can be removed from the surroundings. Uterine myoma, also known as leiomyoma or fibroid is a benign tumor that is often found in women of reproductive age (20-25%). At age> 35 years the incidence is higher, that is, closer to 40%. The high incidence of uterine myomas between the ages of 35 and the ages of 50 indicates a relationship between the incidence of uterine myomas and estrogen.
Uterine Myoma, Risk Factor and Pathophysiology: A Review Articlesemualkaira
Uterine myoma is a benign neoplasm composed of uterine smooth muscle and connective tissue that supports it and is often referred to as fibromyoma, leiomyoma, fibroids. Can be single or multiple and reach large sizes (100 pounds). It has a tough consistency, with a clear cap boundary so that it can be removed from the surroundings. Uterine myoma, also known as leiomyoma or fibroid is a benign tumor that is often found in women of reproductive age (20-25%). At age> 35 years the incidence is higher, that is, closer to 40%. The high incidence of uterine myomas between the ages of 35 and the ages of 50 indicates a relationship between the incidence of uterine myomas and estrogen.
Uterine Myoma, Risk Factor and Pathophysiology: A Review Articlesemualkaira
Uterine myoma is a benign neoplasm composed of uterine smooth muscle and connective tissue that supports it and is often referred to as fibromyoma, leiomyoma, fibroids. Can be single or multiple and reach large sizes (100 pounds). It has a tough consistency, with a clear cap boundary so that it can be removed from the surroundings. Uterine myoma, also known as leiomyoma or fibroid is a benign tumor that is often found in women of reproductive age (20-25%). At age> 35 years the incidence is higher, that is, closer to 40%. The high incidence of uterine myomas between the ages of 35 and the ages of 50 indicates a relationship between the incidence of uterine myomas and estrogen.
Uterine Myoma, Risk Factor and Pathophysiology: A Review ArticleEditorSara
Uterine myoma is a benign neoplasm composed of uterine smooth muscle and connective tissue that supports it and is often referred to as fibromyoma, leiomyoma, fibroids. Can be single or multiple and reach large sizes (100 pounds). It has a tough consistency, with a clear cap boundary so that it can be removed from the surroundings. Uterine myoma, also known as leiomyoma or fibroid is a benign tumor that is often found in women of reproductive age (20-25%). At age> 35 years the incidence is higher, that is, closer to 40%. The high incidence of uterine myomas between the ages of 35 and the ages of 50 indicates a relationship between the incidence of uterine myomas and estrogen.
Similar to 163473537 case-report-katarina-maria-docx (20)
This document provides an overview of the business process outsourcing (BPO) industry. It discusses the growth of the global BPO market, with India emerging as a major hub due to its large English-speaking workforce and lower costs compared to countries like the US. The document outlines the advantages that have made India and other countries like the Philippines competitive locations for BPO. It also notes some of the challenges that countries face in attracting BPO work, such as China's smaller English-speaking population.
This case study examines the success of IKEA's expansion into the American market. Key factors in IKEA's success include its Scandinavian designs, cost efficiency through flat packaging and customer assembly, and structured product strategy using a pricing matrix. While shopping at IKEA has downsides like durability issues and assembly requirements, the company aims to build partnerships with customers. IKEA plans to open 50 stores in the US by 2013, which some see as optimistic but achievable given their value proposition. Minor adjustments to the pricing matrix and additional product styles and price points could support IKEA's continued growth goals. Expanding into smaller "IKEA Lite" stores is also proposed to increase accessibility and impulse purchases.
- Judge Adoracion Angeles charged lawyer Thomas Uy with violating his fiduciary duties by failing to promptly return 16,500 pesos paid to him in trust for his client, Primitiva Del Rosario. During a court hearing, Del Rosario said she did not receive the money from Uy. Uy was then ordered to return the money but failed to do so.
- In his comment, Uy explained that the money was paid to his office by Norma Trajano on December 14, 1998 to settle the civil aspect of a criminal case. He claims Primitiva Del Rosario asked for the money to be kept in his office until further payments were made. However, during a February 10,
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
Assessment and Planning in Educational technology.pptxKavitha Krishnan
In an education system, it is understood that assessment is only for the students, but on the other hand, the Assessment of teachers is also an important aspect of the education system that ensures teachers are providing high-quality instruction to students. The assessment process can be used to provide feedback and support for professional development, to inform decisions about teacher retention or promotion, or to evaluate teacher effectiveness for accountability purposes.
Executive Directors Chat Leveraging AI for Diversity, Equity, and InclusionTechSoup
Let’s explore the intersection of technology and equity in the final session of our DEI series. Discover how AI tools, like ChatGPT, can be used to support and enhance your nonprofit's DEI initiatives. Participants will gain insights into practical AI applications and get tips for leveraging technology to advance their DEI goals.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Thinking of getting a dog? Be aware that breeds like Pit Bulls, Rottweilers, and German Shepherds can be loyal and dangerous. Proper training and socialization are crucial to preventing aggressive behaviors. Ensure safety by understanding their needs and always supervising interactions. Stay safe, and enjoy your furry friends!
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
1. Get Homework/Assignment Done
Homeworkping.com
Homework Help
https://www.homeworkping.com/
Research Paper help
https://www.homeworkping.com/
Online Tutoring
https://www.homeworkping.com/
click here for freelancing tutoring sites
2. OBSTETRIC AND GYNECOLOGIC
MEDICAL FACULTY
CHRISTIAN UNIVERSITY OF INDONESIA
DECEMBER, 3RD 2012 –FEBRUARY,2ND 2013
Menorrhagia, Pain, and Constipation in Uterine Myoma
Tigor P. Simanjuntak,1 Katarina Maria2
1 Obstetric and Gynecology DepartmentChristian University of Indonesia
2 College Student Medical Faculty Christian University of Indonesia
3. Abstract
Uterine myoma are benign neoplasms of uterine smooth muscle cells, that typically
originate from the myometrium. It also known as myomas or fibroids. The insidence in
Indonesia was 2,39-11,7 %, happened between 36 and 49 years old women. 20% of all
women of reproductive age. The highest proportion was 5-10 cm (67,5%). Multipara parity
women 45,2% .Intramural myoma 41,9%, Prolonged menstruation 37,3%. Heavy menstrual
bleeding 59,8%. Chronic pelvic pain was 14.5%. 28,8% pressure symptom cause intestinal
obstruction. Pain during menstrual period 59,7%. Uterine myoma still become one of the
problem in Gynecology. This paper will report the menorrhagia, pain, and constipation in
P3A1woman.
Keyword : Uterine Myoma, menorrhagia, pain, constipation
Introduction
Uterine myomas are benign neoplasms of uterine smooth muscle cells, that typically
originate from the myometrium. It also known as leiomyomas or fibroids, are by far the most
common benign uterine tumors.The uterine leiomyomas are the most common pelvic tumors
in women of reproductive age.(1-10)
The etiology of this common tumor is not known.(1)However, the relative
contributions of estrogen vs. progesterone and their functions in the pathogenesis of uterine
leiomyomas are still controversial.(9)Leiomyomas develop during the reproductive years and
regress in size and incidence after menopause.(3)So that, Leiomyomas are not detectable
before puberty and being hormonally responsive, normally grow only during the reproductive
years.(1)
4. There are some conditions associatedwith increased estrogen production that
encourage leiomyoma formation. For example, the increased years of estrogen exposure
found with early menarche and with an increased body mass index (BMI). Obese woman
who poduce more estrogens from increased adipose conversion of androgens to estrogen are
each linked with a greater risk of leiomyomas. Because the pregnancy is a progesterone
dominant state,it should provide an interlude from chorionic estrogen exposure, and
intuitively at least, should discourage leiomyoma development.(3)
While the role of progesterone in leiomyoma growth is less clear, and indeed both
stimulatory and inhibitory effects have been reported. For example, exogenous progestins
have been shown to limit leiomyoma growth. For example, antiprogestin induces athrophy in
most leiomyomas.(3)
Beside the hormone, the etiology of leiomyomas are related to the cytogenetic
abberation. Although most of uterine leiomyomas have a normal karyotype, there have been
reports suggesting that 50% of these tumors bear specific chromosomal abberations including
chromosome 3,6,7 trisomy 12, reciprocal translocation and monosomy 22. Such
chromosomal rearrangements may be responsible for initiatin as well as the growth of these
tumors with a significant relationship between clonal cytogenetic abnormalities and myoma
size. (5)
Duringthe reproductive years, the incidence of Leiomyomas increases with age.(3)
They are
estimatedto be present in at least 20% of all women of reproductive age, may be discovered
incidentally during routine annual examination.(2)
In the studies at 2011, the uterine
myomahappened between 36 and 49 years old women.(7)
The cumulative incidence by age 50 years
was nearly70% inCaucasiansand over80% in African- Americanwomen.(9)
So that,Leiomyomas are
more common in African-American women compared with Caucasian, Asian, or Hispanic
women.(3)
Proportion uterine myoma in Indonesia 2,39-11,7% from all hospitalized benign
gynecology.(12)
Family and twin studies have shown the risk of leiomyoma formation to be
approximatelytwotimesgreaterinwomenwithaffectedfirst- degree relatives.(3)
Thus far, the only
known genetic factor conferring a high risk for developing uterine leiomyomas are the germline
mutationsinthe fumareatehydratase (FH) gene, an enzyme of the tricarboxylic acid cycle.(4)
For the
womenwhosmoke generallyhave alowerriskforleiomyomaformationbecause the smoking alters
estrogenmetabolismandlowersphysiologicallyactive serumestrogenlevels.(3)
The studyat Pirngadi
Hospital reported that based on the parity the highest proportion was multipara parity women
45,2% and the lowest was primi parity with 13,4%. (12)
Leiomyomas contain estrogen receptors in higher consentrations than the surrounding
myometrium. Progesterone increases the mitotic activity of myomas in youngwomen,
progesterone may also allow for tumor enlargement by downregulating apoptosis in the
tumor. Leiomyomas are usually multiple, discrete, and either spherical or irregularly
lobulated. Leiomyomas have a false capsular covering, and they are clearly demarcated from
surrounding myometrium. Which allows easy enucleation at the same time of surgery. There
5. is usually one major blood vessel suplying each tumor. The cut surface is characteristically
whorled. (2)
They are usually less than 15 cm in size.(1)The study at RS Pirngadi Medan reported,
based on the size, the highest proportion was 5-10 cm (67,5%) and the lowest was > 10cm
(11,1%).(12)The appearance of leiomyomas may vary when normal nuscle tissue is replaced
with various degenerative substances following hemorrhage and necrosis. This proces is
termed degeneration and these gross changes should be recognised as normal variants.
Degeneration in leiomyoma because of the limited blood supply within these tumors.
Leiomyomas have a lower arterial density compared with the surrounding normal
myometrium. (3)
Uterine leiomyomas are classified by anatomic location. Submucous leiomyomas lie
just beneath the endometrium and tend to compress it as they grow toward the uterine lumen.
Their impact on the endometrium and its blood supply most often leads to irreguler uterine
bleeding. Intramural or interstitial leiomyomas lie within the uterine wall, giving it a variable
consistency. Subserous leiomyoma may also become pedunculated. If such a tumor acquires
an extrauterine blood supply from omental vessels, its pedicle may athrophy and
resorb.(2)Based on anatomic location, the most was intramural myoma 41,9%, submucous 37,2%,
and subserouswas32,6%.(12)
Symptoms are present in only 35-50% of patients with leiomyomas. Thus, most
leiomyoma do not produce symptoms, and even very large ones may remain undetected,
particularly in obese patient. Symptoms from leiomyomas depend on their location size, state
of preservations, and whether or not the patient is pregnant. Abnormal uterine bleeding is the
most common and mostimportant clinical manifestation of leiomyomas, being present in up
30% of patients.(1)The bleeding related to dilatation of venules.Bulky tumors are thought to
exert pressure and impinge on the uterine venous system, which causes venular dilatation
within the myometrium and endometrium. Accordingly, intramural and subserous tumors
have been shown to have the same propenstiy to cause menorrhagia as mucous ones.
Dysregulation of local vasoactive growth factors are also thought to promote vasodilatation.
When engorged venules are disrupted at the time of menstrual sloughing, bleeding from the
markedly dilated venules overwhelms usual hemostatic mechanisms.(3)
The abnormal bleeding commonly produces iron deficiency anemia, which may not
be uncontrollable even with iron therapy if the bleeding is heavy and protracted. Most
commonly, the patients has prolonged,menorrhagia, premenstual spotting, or prolonged light
staining following menses; however, any type of abnormal bleeding is posible.Metrorrhagia
may be assosiated with a tumor that has areas of endometrial venous thrombosis and necrosis
on its surface, particularly if it is pedunculated and partially extruded through the cervical
canal.(1) 37,3% of women with diagnosed uterine myoma reported a significantly longer
duration of period (5.6 ± 3.1 days, n = 1,245) than women without a diagnosis of uterine
myoma. Shortened duration of menstrual bleeding 13,1%.Heavy menstrual bleeding 59,8% ,
irregularperiods36,3%, Frequentperiods (periodsoccurmore often than just every 24 days) 28.4%,
Infrequent periods (periods occur less often than every 38 days) 16,7%.(11)
6. A sufficiently enlarged uterus can cause pressure sensation, urinary frequency,
incontinance, and constipation. Rarely, leiomyomas extend laterally to compress the ureter
and lead to obstruction and hydronephrosis.(3)
Pressure on the bladder or inside the abdomen
32,6%. (11)
Pressure symptom happened in 28,8% women with uterine myoma. (12)Pressure
effects may cause intestinal obstruction if they are large or involved omentum or
bowel.Although dysmenorrhea is common, in a population based cross sectional study,
Lippman and co-workers reported thatwomen with leiomyomas more frequently had
dyspareunia or noncyclical pelvic pain than dysmenorrhea.(3)
Leiomyomas may cause pain when vascular compromise occurs. Thus, pain may
result from degeneration associated with vascular occlusion, infection, torsion of a
pedunculated tumor, or myometrial contraction to expel a subserous myoma from the uterine
cavity. The pain associated with infarction from torsion or red degeneration can be
excruciating and produce a clinical picture consistent with acute abdomen.Large tumor may
produce sensation of heaviness or fullnes in the pelvic area, a feeling of a mass in the pelvis,
or a feeling of a mass palpable through the abdominal wall. Tumors that become impacted
within the bony pelvis may presson nerves and create pain radiating to the back or lower
extremities.(1)The incidence of chronic pelvic pain was 14.5%. Pain during menstrual
bleeding or period was 59,7%.Cramping during menstrual period was 50.2%.Pain after
menstrual periodwas 16,7% while painful sexual intercoursewas 23,5%.(11)
Although the mechanism are not clear, leiomyomas can be associated with infertility.
It is estimated that 2to 3 % of infertility cases due sorely to leiomyomas. Their putative
effects include occlusion of tubal ostia and disruption of the normal uterine contractions that
properl sperm or ovum. Distortion of the endometrial cavity may diminish implantation and
sperm transport. Importantly, leiomyomas are associated with endometrial inflammation and
vascular changes that may disruptimplantation.(3)
Thereis a stronger associationof subfertility with submucous leiomyomas than with
tumors located elsewhere. Improved pregnancy rates following hysteroscopic resection have
provided most of the indirect evidance for this link. In one study, Garcia and Tureck reported
pregnancy rates approaching 50% following myomectomy in women with submucos
leiomyomas as their sole source of infertility.(3)
The incidence of spontaneous abortion secondary to leiomyoma is unknown but is
possibly 2 times the incidence in normal pregnant women. For example, the incidence of
spontaneous abortion prior to myomectomy is approximately 20%.(1)
Most myomas arediscovered by routine bimanual examination of the uterus or
sometimes by palpation of the lower abdomen. Uterine retroflexion and retroversion may
obscure the physical examination diagnosis of even moderetly large myoma. When the cervix
is pulled up behind the symphisis, large fibroids are usually implicated. The diagnosis is
obvious when the normal uterine contour is distorted by one or more smooth, spherical, firm
masses, but often it is difficult to be absolutley certain that such masses are part of the
uterus.(1)
7. As noted earlier, anemia is a common consequence of leiomyomas due to excessive
uterine bleeding and depletion of iron reserves. However, occasional patients display
erythrocytosis. The hematocrit returns to normal levels following removal of the uterus, and
elevated erythropoietin levels have been reported in such cases.Moreover, the recognized
association of polycythemia and renal disease has led to speculation that leiomyomas may
compress the ureters to cause ureteral back pressure and thus induce real erythropoietin
production. Leukocytosis, fever, and an elevated sedimentation rate may be present with
acute degeneration or infection.
Pelvic ultrasound examination are useful in confirming the diagnosis of leiomyomas.
While ultrasound should never be a substitute for a thorough pelvic examination, it can be
extremely helpful in identifying leiomyomas, detailing the cause of other pelvic masses, and
in the identification of pregnancy. Moreover, the ultrasonography is particularly useful in the
obese individual. (1)
The sonographic appearance of leiomyomas vary from hypo to hyperechoic,
depending on the ratio of smooth muscle to conective tissue and whether there is
degeneration. If menorrhagia, dysmenorrhea, or infertility accompanies a pelvic mass, then
the endometrial cavity should be evaluated for submucous leiomyomas, endometrial polyps,
congenital anomalies, or synechiae.Leiomyoma have characteristic vascular patterns that can
be identified by color flow Doppler. A peripheral rim of vascularityfrom which few vessels
arise to penetrate into the center of the tumor is traditionally seen. Doppler imaging can be
used to differentiate an extrauterine leiomyoma from other pelvic masses or submucous
leiomyoma from endometrial polyp or adenomyosis. (3)
In the diagnosis of myomas, MRI demonstrated sensitivity of 94,1 %, specificity of
68,7%,PPV pf 95,7%, and NPV of 61,1%. The Area Under the Curve (AUC) for the
diagnostic perfomance of MRI in the detection of mymoas was 0,81, respectively. MRI
exhibits a high AUC for the diagnosis of myomas. MRI seems to be a useful technique in
everyday clinical practice in the diagnosis approach of these common condition, enabling
clinicians to select the most appropriate management.(6)
Choice of treatment depends on the patient’s age, parity, pregnancy status, desire for
fture pregnancies, general heath, and symptoms, as well as the size, location, and state of
preservation of the leiomyomas.Blood transfusins ma be necessary to correct anemia.
Transfusion of packed red cells is preffered over whole blood. (1)
In some women with symptomatic leiomyomas, medicaltheraphy may be preffered.
Women with dysmeorrhea have higher endometrial levels of prostaglandins than
asymptomatic women. Accordingly, treatment of dysmenorrhea and menorrhea assosiated
with leiomyomas is based in the role of prostaglandins as mediators of these symptoms. A
number of NSAIDs have proved effective for dysmenorrhea, yet there is not one considered
to be superior. Prostaglandin are also associated with menorrhagia.(3)
The gonadotropin releasing hormone (GnRH) agonist have proven very useful for
limiting growth or to cause a temporary decrease in tumor size. GnRH induce hypogonadism
8. through pituitary desensitization, downregulation of receptors, and inhibition of
gonadotropins. (1)
Table 1 : Dosages of GnRH Agonists
Brand Name Generic Name Dosage
Decapeptyl Triptorelin 3,75mg depot IM monthly
Lupron Leuprolide acetate 3,75mg depot IM monthly
Zoladex Goserelin 3,6 mg depot SC monthly
Synarel Nararelin 200 mg taken twice daily as
1 spray
The progesterone receptor modulators make up an interesting group of compounds.
The almost pure antagonist of the progesterone receptors, such as mifepristone with 5 or 10
mg daily during 6 months had a similar efficacy in reducing the uterine myoma volume,
48,1% and 39,1%.(7)
Two randomised double-blind studies have shown the effectiveness of the
progesterone receptor modulator ulipristal acetate (UPA) in the preoperative treatment of
uterine fibroids and in the control of a concomitant hypermenorrhea. A dosage of 5 or 10 mg
UPA over three months has produced no significant sideeffects. A cessation of the
hypermenorrhea has been observed after only seven days, a volume reduction of the uterine
myoma by 40% within three months seemed to be visible even six months after stopping the
therapy.(10)
Some indication for surgery are abnormal uterine bleeding with resultant anemia,
unresponsive to hormonal management. Chronic pain with severe dsmenorrhea, dyspareunia,
or lower abdominal pressure or pain. Acute pain as in torsion of a pedunculated leiomyoma
or prolapsing submucosal fibroid, urinary symptoms or signs such as hydronephrosis after
complete evaluation. Infertility with leiomyomas as the only abnormal finding. Markedly
enlarged uterine size with compression symptoms or discomfort.(2)
Removal of the uterus is the definitive and most common surgical treatment for
leiomyomas. Hysterectomy for leiomyoma can be performed vaginally, abdominally, or
laparoscopically.(3)Uterine with small myomas may be removed by total vaginal
histerectomy, particularly if vaginal relaxation demands repair of cystocele, rectocele, or
enterocele. When numerous large tumors especially intraligamentary myomas are found,total
abdominal histerectomy is indicated. Other considerations prior to hysterectomy include
uterine size and preoperative hematocrit. In some cases,preoperative GnRH agonist may
provide advantages.(1)
Myomectomy should be planned for the symptomatic patient who wishes to preserve
fertility or conserve the uterus or for those who decline histerectomy, but one can never be
certain before operation that myomectomy can accomplished easily. Myomectomy is quite
9. succesful for control of chronic bleeding association with leiomyomas. Increasingly
myomectomy is being performed through the histeroscope in cases of submucous leiomyoma
and through the laparoscope of subserous leiomyoma.(1)
Myolysis is one of the procedures that is claimed to provide significant improvement
in myoma status without hysterectomy. Myolysis procedures have been generally performed
via laparoscopy, and there are limited data on transvaginal radiofrequency (RF) myolysis.
Mean baseline volume of the dominant myomas was 304.6+229.1 cm3 and its volume at 3
months following RF myolysis decreased compared with the previous examination (P ¼
0.002). An improvement of menorrhagia occurred 1, 3, 6 and 12 months after operation (all P
, 0.001 versus baseline). Overall symptoms at 1, 3, 6 and 12 months after RF myolysis also
improved (all P , 0.001 versus baseline). No major complications were observed or reported.
After 12 months, three patients had successfully conceived and delivered and there were no
complications during labor or delivery. Transvaginal ultrasound-guided RF myolysis might
be a safe, effective and minimally invasive outpatient procedure for uterine myoma in terms
of size reduction, symptom improvement and safety.(8)
Leiomyosarcoma are reported to developed with a frequency of 0,1- 0,5% that of
diagnosed leiomyomas.(1,2)Disadvanageously, postoperative intra abdominal adhesions
leiomyoma recurrence are more common aftermyomectomy compared with hysterectomy.
Recurrence rates following myomectomy range from 40 to 50%. New leiomyoma
development, however,diminished in women who become pregnant following myomectomy,
perhaps because of protective effect of increasingparity.(3)While in the other study, reported a
rate of 2-3% per yearof symptomaticmyomas after myomectomy.(1). Myomectomy usually
improves pain, infeertility, or bleeding. Menorrhagia improves in approximately 70-80% of
patients.(3)Ureteral injury or ligation is a well- recognized complication of surgery for
leiomyomas, particularly cervical.(1)
Case Report
Patient Identity:
Name : Miss. Rohayati
MR : 01.03.04.00
Age : 42 Years 10 months
Address : Cawang 3 Jl. Usman Harun no 8 RT 01/05, Kebon Pala, Jakarta Timur.
Date of Entry : December, 17th 2012.
10. Main Complaint : Vaginal Bleeding.
Additional Complaint : Lower Abdominal Pain.
History of Present Illness :
The patient came to UKI hospital with complaints of vaginal bleeding since about 6
days before entering the hospital. The patient said that the blood was blackish red and she had
a prolonged menstruation, 6 days. Within a day, the patient changes the bandage around 3-4
times. The first day of the last menstruation was December,11th 2012. Sometimes, she
complained of pain when menstruation. In addition, the patient complained of pain in the
lower abdomen, such as knead. Besides, the patient said that she had a constipation but has
no complained about bladder.
Previous Disease History:
The patient once had a complaint of vaginal bleeding in March 2010. The blackish red blood
came out. Within a day, the patient can change the bandage about 4 times. Patients also
complained of lower abdominal pain. The patientwastreatedto Kartika Pulomas hospitalwith
adiagnosis ofuterine myoma. The Patientalsounderwentsurgery inApril 2010. None of her
family has the same complaint.
Menstrual History :
The first period of menstruation : 16 years old.
Menstrual Cycle :
Cycle : Regular( 30days).
Duration : 6 days
Quantity : 4x changes the bandage/ ± 200 cc.
Pain during menstruation : + take the medicine : -
Menstruation last 3 months
Table 2 : Menstruation last 3 months
Date Month Year Lenght Amount
11 12 2012 6 days ± 200 cc
11 11 2012 6 days ± 200 cc
11 10 2012 6 days ± 200 cc
11. History of Marriage
Marriage : one time
Last marriage old : 16 years.
History of Pregnancy and Childbirth Ago
Previous Pregnancies : P 3 A 1
The number of children alive : 2 children
General examination
Vital Signs
General State : Looks Moderate Illness
Awareness : Composmentis
Blood Pressure : 160/ 70 mmHg
Pulse : 80x / menit
Temperature : 36,5 C
Respiration Rate : 20 x / minute
Body Weight : 70 kg
Eyes : Conjunctiva was not pale, no jaundice sclera, tear +
Ears : Normotia, spacious ear canal, serumen -/-
Nose : Spacious nose canal, sekret -/-, septum deviasi (-),
Mouth : Lips mucosa moist
Tonsil : T1 – T1, Calm
Faring : Not hiperemis
Neck : Trachea in the middle, no palpable lymph glands enlarge
Toraks
inspection : Movement of the chest wall left and right symmetric
Intercostal retraction (-)
Palpation : Vocal fremitus left and right
12. Percussion : Percussion comparison of left and right symmetric resonant
Auscultation : Basic breath sounds vesicular
Ronkhi -/-, Wheezing -/-
Heart sounds I and II normal, murmurs (-), gallop (-)
Abdomen
Inspection : Abdomen looks flat
Auscultation : Bowel sounds (+) normal: 4x/minute
Palpation : Supple stomach, liver and spleen not palpable enlarged. Turgor enough
Percussion : Tympani
Extremities : Warm Acral + / +, capillary refill <2 seconds, good movement in all
directions, muscle tone normotonus.
Ginecology Examination
Face : looks symetric
Breast : Retraction (-), tenderness (-).
External Genitalia
Distribution of pubic hair : prevalent
Fluksus : (+) not active
Fluor : (+)
Vulva : Bump (-)
Pain (-)
Internal Examination
V-U-V :Calm, mass (-), portio springy, bouncy pain (-).
The uterus of an adult fist, tenderness (-).
Adnexal mass - / -, tenderness - / -, not prominent cavum of Douglas.
Diagnosis: Uterine myoma + Menorrhagia.
Working Diagnosis: Uterine myoma +Myomectomy history 1x + DM type II + Hypertension.
Prognose : Ad vitam : Ad bonam
13. Ad Functionum : Dubia ad malam
Ad Sanationam : Dubia ad malam
Therapy : 1. hospitalization
2. Observation of general condition, vital signs, abdominal pain, and bleeding.
3. Complete blood lab tests, SGOT, SGPT, MP3, urea, creatinine,
Electrolytes, Present blood sugar, HBsAg, complete urine, plano test, chest X-ray, ECG.
4. Pro USG
5. Diet: Regular
6. IVFD: RL
7. mm/ : Ciprofloxacin 2 x 500 mg.
Kalnex 3 x 1 ampul.
Mefenamic Acid 3 x 500 mg.
8. Total hysterectomy with General Anesthesi planning : January, 2nd 2013.
Uterusof the fist with adhesions. The left tuba, left ovary, and portio was
left.
Table 3: Daily Follow Up
Date SOAP
December, 18th 2012 S: Lower abdominal pain
Blood of the pubic
O: GC: Look Moderate Illness (LMI)
Awareness : composmentis
Blood Pressure : 100/ 60 mmHg
Pulse : 80x/ minute
Temperature : 37, 1 oC
RR : 16 x/ minute
Eyes : Anemis -/-, Jaundice -/-.
Extremity : Warm, CRT < 2”.
Abdomen: Abdomen looks flat, flexible,
palpable mass of an adult fist, Tender (-),
timpani, word of pain (-).
Noisy intestine (+)
Genital: fluorine (-), fluksus (+) is not active.
Hb : 13,6 g/ dL
14. Leukocyt : 22 thousand/uL
Hematocryt: 40,5 %
Trombocyt : 284 thousand/uL
Bleeding time :1.3 minutes
Clotting time : 12 minutes
Protrombin time : 12 seconds
GOD - POD : 145 mg/dL
HbA1c : 7,8 %
USG: Uterus : 12 x 9 x 9.5 cm
Myoma : 7,01 x 5,9 cm
Impression: Uterine myoma
A: Uterine myoma + myomectomy history+
DM type II + Hypertension
P: Pro Gynecology USG
Diet : Reguler
IVFD : I RL
Mm/ : Ciprofloxacin 2 x 50 mg.
Tranexamat Acid 3 x 1 ampul
Mefenamic Acid 3 x 500 mg
Norelut 3 x 1
Captopril 2 x 2,5 mg (stop)
19 December 2012 S: Blood of genitals reduced
O: GC : Looks Mild illness
Awareness: CM
Eyes : anemis -/-, Jaundice -/-
Extremities : warm, CRT <2”
Mammae : tenderness -, retraction -, mass-
Abdomen: Abdomen looks flat, supple,
muscular defense (-), timpani, tenderness (+),
palpable mass (+) flat surface, smooth,
mobile, assertive, bowel (+) 3x / min.
Genitals: Fluor (-), fluksus (+) slightly.
Natrium : 154 mmol/L
Kalium : 3,5 mmol/L
Chloride: 112 mmol/L
Total protein 7,19 g/dL
Albumin : 3, 06 g/dL
Globulin : 3, 33g/dL
SGPT : 25 U/L
SGOT : 31 U/L
Total Cholesterol : 343 mg/ dL
Trigleseride : 123 mg/dL
HDL Cholesterol 52 mg/dL
LDL Cholesterol 174 mg/dL
A: Uterine myoma + post miomektomy +
DM + Hypertension
P: Diet : DM
IVFD : RL ( 20 drop/minute)
Mm/ : Ciprofloxacin 2 x 500 mg (III)
Tranexamat Acid 3 x 500 mg
15. Mefenamic Acid 3 x 500 mg
Norelut 3 x 10 mg
Examination : Elektrolit, Hb, HbA1C.
December,20th 2012 S: difficult defecation
O: GC: Looks Mild Illness
Awareness: CM
Blood Pressure: 140/90 mmHg
Pulse : 84x/ minute
Temperature : 36, 5 oC
RR : 22x /minute
Eyes : anemis -/-, Jaundice -/-
Ekstremities : Warm, CRT <2”
Edema -/-/+/+.
Mammae : tenderness -, retraction -, mass-
Abdomen: Abdomen looks flat, supple,
muscular defense (-), tenderness (-), palpable
mass (+), bowel sounds (+) 3x / min.
Genitals: fluorine (-), fluksus (-).
GOD – POD :124 g/dL
A: Uterine myoma + post miomektomy +
DM + Hypertension.
P: Diet : DM + papaya extra.
IVFD: RL ( 20 drop/minute) + KCl 50 meq
Mm/: Ciprofloxacin 2 x 500 mg
Tranexamat Acid 3 x 500 mg
Mefenamic Acid 3 x 500 mg
Norelut 3 x 10 mg
Metformin 2 x 500mg
Discussion
In the studies at 2011, the uterine myoma happened between 36 and 49 years old
women, while the patient is 42 years old.(7).The patient complaints of vaginal bleeding since
about 6 days.This complaintsdue to the symptoms based on the theory thatabnormal uterine
bleeding is the most common and most important clinical manifestation of leiomyomas,
being present in up 30% of patients.(1)The bleeding related to dilatation of venules.Bulky
tumors are thought to exert pressure and impinge on the uterine venous system, which causes
venular dilatation within the myometrium and endometrium. Accordingly, intramural and
subserous tumors have been shown to have the same propenstiy to cause menorrhagia as
mucous ones.(3)The patients also had a prolonged menstruation,it was reported that 37,3% of
women with diagnosed uterine myoma had a significantly longer duration of menstruation
period (5.6 ± 3.1 days, n = 1,245). (11)
The patient complained of pain in the lower abdomen. It’s suitable with the symptom
that Leiomyomas may cause pain when vascular compromise occurs. Thus, pain may result
16. from degeneration associated with vascular occlusion, infection, torsion of a pedunculated
tumor, or myometrial contraction to expel a subserous myoma from the uterine cavity. The
pain associated with infarction from torsion or red degeneration can be excruciating and
produce a clinical picture consistent with acute abdomen.(2). The incidence of chronic pelvic
pain was 14.5% whilepain during menstrual bleeding or period was 59,7%.(11)
The patient also complained of constipation because pressure effects may cause
intestinal obstruction if they are large or involved omentum or bowel.(1)Pressure symptom
happened in 28,8% women with uterine myoma. (12)
The abnormal bleeding commonly produces iron deficiency anemia, which may not
be uncontrollable even with iron therapy if the bleeding is heavy and protracted. This
symptom didn’t happened in this patient. (1).
A sufficiently enlarged uterus can cause pressure sensation, urinary frequency,
incontinance, and constipation. Rarely, leiomyomas extend laterally to compress the ureter
and lead to obstruction and hydronephrosis. (3)Pressure on the bladder or inside the abdomen
happened in 32,6% women with uterine myoma (11)
butthe patient didn’t complained it.
Although the mechanism are not clear, leiomyomas can be associated with infertility. It is
estimatedthat2 to 3 %of infertilitycasesdue sorely to leiomyomas. Their putative effects include
occlusion of tubal ostia and disruption of the normal uterine contractions that proper sperm or
ovum. Distortion of the endometrial cavity may diminish implantation and sperm transport.
Importantly,leiomyomas are associated with endometrial inflammation and vascular changes that
may disrupt implantation.(3)
The study at Pirngadi Hospital reported that based on the parity, the
highestproportionwasmultiparaparitywomen45,2%. (12)
Thissymptompossiblydidn’thappenedin
this P3A1 woman because she got the myoma after she had 2 children.
The patient is Asian which is Asian was at the third races that possible to get uterine
myoma.(3)Family and twin studies have shown the risk of leiomyoma formation to be
approximately two times greater in women with affected first- degree relatives, but the
patient didn’t have the familial history of uterine myoma.(3)
Most myomas are discovered by routine bimanual examination of the uterus or
sometimes by palpation of the lower abdomen. In this case, the mass was palpable in this
patient lower abdomen. (1)
The Pelvic ultrasound examination are useful in confirming the diagnosis of
leiomyomas. While ultrasound should never be a substitute for a thorough pelvic
examination, it can be extremely helpful in identifying leiomyomas, detailing the cause of
other pelvic masses, and in the identification of pregnancy, the USG result for this patient
was myoma uterine 7,01 x 5,9 cm.(1)
In the diagnose of myomas, MRI demonstrated sensitivity of 94,1 %, specificity of
68,7%,PPV pf 95,7%, and NPV of 61,1%. The Area Under the Curve (AUC) for the
diagnostic perfomance of MRI in the detection of mymoas was 0,81, respectively. MRI
17. exhibits a high AUC for the diagnosis of myomas. In this case, we didn’t use it for the
patient. (6)
In this case, the total hysterectomy was planned for this patient at January, 2nd 2013.
This is based on the theory that removal of the uterus is the definitive and most common
surgical treatmet for leiomyomas. Hysterectomy for leiomyoma can be performed vaginally,
abdominally, or laparoscopically. Uterine with small myomas may be removed by total
vaginal histerectomy, particularly if vaginal relaxation demands repair of cystocele, rectocele,
or enterocele. When numerous large tumors especially intraligamentary myomas are found,
total abdominal histerectomy is indicated. (1)
Myomectomy should be planned for the symptomatic patient who wishes to preserve
fertility or conserve the uterus or for those who decline histerectomy, but one can never be
certain before operation that myomectomy can accomplished easily. In this case, the patient
preffered total hysterectomy than myomectomy. (1)
Postoperative intra abdominal adhesions leiomyoma recurrence are more common
after myomectomy compared with hysterectomy. Recurrence rates following myomectomy
range from 40 to 50%. New leiomyoma development, however,diminished in women who
become pregnant following myomectomy, perhaps because of protective effect of increasing
parity.(3)While in the other study, reported a rate of 2-3% per year of symptomatic myomas
after myomectomy.(1)In this case, the patient have a uterine myoma with myomectomy
history in 2010.
Conclution
The conclution of these case report is Uterine Myoma are benign neoplasms
composed primarily of uterine smooth muscle cells, that typically originate from the
myometrium.It also known as myomas or fibroids. (1-10).
Incidenceof uterine myoma in Indonesia 2,39-11,% from all hospitalized benign
gynecology.(12)
, happened between 36 and 49 years old women(7)
, 20% of all women of
reproductive age.(2)
The cumulative incidence byage 50 yearswas nearly70% inCaucasiansand over
80% inAfrican- Americanwomen.(9)
The incidence in multipara parity women 45,2%. (12)
The highest
proportion was 5-10 cm (67,5%). (12)
The most happened location was Intramural myoma
41,9%(12)).
Abnormal uterine bleeding is the most common and most important clinical
manifestation of leiomyomas, being present in up 30% of patients.(1) The incidence of heavy
menstrual bleeding 59,8%, , Prolonged menstruation 37,3% (11)
While the incidenceof chronic
pelvic pain was 14.5%, pain during menstrual period 59,7%..(11)
The incidence of pressure
symptom cause the intestinal obstructin was 28,8%. (11)
It is estimated that 2 to 3 % of
infertility cases due sorely to leiomyomas.(3)
18. Pelvic ultrasound examination are useful in confirming the diagnosis of
leiomyomas.(1)MRI demonstrated sensitivity of 94,1 %, specificity of 68,7%. (6)The
gonadotropin releasing hormone (GnRH) agonist have proven very useful for limiting growth
or to cause a temporary decrease in tumor size. (1)Progesterone receptors, such as
mifepristone with 5 or 10 mg daily during 6 months had a similar efficacy in reducing the
uterine myoma volume, 48,1% and 39,1%.(7).
Leiomyosarcoma are reported to developed with a frequency of 0,1- 0,5% that of
diagnosed leiomyomas. (1,2)Recurrence rates following myomectomy range from 40 to 50%.
(3)Ureteral injury or ligation is a well- recognized complication of surgery for leiomyomas,
particularly cervical.(1)
.
Bibliography
1. Sanaz M, Broder MS, Wexler AS, Permoll ML. Benign Disorder of the Uterine Corpus.
DeCherney AH. Current Obstetric & Gynecologic Diagnosis & Treatment. 9th eds. India:
McGraw-Hill Companies.2003: 693-707.
2. Hillard,PJA. Benign Diseases of the Female Reproductive Tract. Berek JS. Novak’s
Gynecology. 13th eds. Philadelphia: Lippincott Williams & Wilkins. 2002: 351-420.
3. Schorge JO,Schaffer JI, Halvorson LM, Hoffman BL, Bradshaw KD, FG Cunningham.
Pelvic Mass. Loeb M, Davis K. Williams Gynecology. China: The McGraw- Hill Companies.
2008: 197-224.
4. Tolvanen J, UimariO.Strong family history of uterineleiomyomatosis warrants fumarate
hydratase mutation screening. HumRep.2012:Vol.27: No.6: 1865-9.
5. El-Gharib MN, Elsobky ES.Cytogenetic aberrations and the development ofuterine
leiomyomata. J. Obstet. Gynecol. Res.2010: Vol.36: No.1: 101-7.
6. Stamatopoulos CP, Mikos T, Grimbizis GF, Dimitriadis AS, Efstratiou I,Stamatopoulos
P,et al. Value of Magnetic Resonance Imaging in Diagnosis of Adenomyosis and Myomas of
the Uterus. JIMG. 2012: Vol.19: No.5: 621-6.
7. Esteve JLC, Acosta R, Pe´ rez R, Campos R,Herna´ndez AV, Texido CS. Treatment of
uterine myoma with 5 or 10 mg mifepristone daily during 6 months, post-treatment evolution
over 12 months: double-blind randomised clinical trial. Eur J Obstet Gynecol Reprod Biol.
2012: Vol 161: 202-8.
8. Kim CH, Kim SR, Lee HA, Kim SH, Chae HD, Kang BM.Transvaginal ultrasound-guided
radiofrequency myolysis for uterine myomas. HumRep. 2011: Vol.26: No.3: 559-563.
9. Ishikawa H, Ishi K, Serna VA, Kakazu R, Bulun SE, Kurita T. Progesterone Is Essential
for Maintenance and Growth of Uterine Leiomyoma. Endojournals. 2010: Vol 151: No.6:
2433-2442.
19. 10. Rabe T, Ahrendt HJ, Albring C, Bitzer J, Bouchard P, CirkelU, et al.Ulipristal acetate for
treatment of symptomatic uterine fibroids and myoma-related hypermenorrhea. Frauenarzt.
2012: Vol.53 : 322-332.
11. ZimmermannA, BernuitD, Gerlinger C, Schaefers M , Geppert K. Prevalence, symptoms and
management of uterine fibroids: an international internet-based survey of 21,746 women. BMC
Women’s Health. 2012 : Vol.12: No.6.
12. Ginting LY, Rasmaliah, Jemadi. Karakteristik Penderita Mioma Uteri yang Dirawat Inap di RSUD
DR.Pirngadi Medan Tahun 2009-2011.Downloaded from:
http//jurnal.usu.ac.id/index.php/gkre/article/download/376/266.January, 21st 2013